Subramaniam Malarkannan

Dr. Subramaniam Malarkannan

Laboratory of Molecular Immunology and Immunotherapy, Department of Medicine, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI 53226, USA

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 August 2018 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
AAAlex M. Abel
Alex M. Abel
CYChao Yang
Chao Yang
MTMonica S. Thakar
Monica S. Thakar
Subramaniam MalarkannanSubramaniam Malarkannan
Subramaniam Malarkannan
Natural killer (NK) cells are the predominant innate lymphocyte subsets that mediate anti-tumor and anti-viral responses, and therefore possess promising clinical utilization. NK cells do not express polymorphic clonotypic receptors and utilize inhibitory receptors (killer immunoglobulin-like receptor and Ly49) to develop, mature, and recognize “self” from “non-self.” The essential roles of common gamma cytokines such as interleukin (IL)-2, IL-7, and IL-15 in the commitment and development of NK cells are well established. However, the critical functions of pro-inflammatory cytokines IL-12, IL-18, IL-27, and IL-35 in the transcriptional-priming of NK cells are only starting to emerge. Recent studies have highlighted multiple shared characteristics between NK cells the adaptive immune lymphocytes. NK cells utilize unique signaling pathways that offer exclusive ways to genetically manipulate to improve their effector functions. Here, we summarize the recent advances made in the understanding of how NK cells develop, mature, and their potential translational use in the clinic.

2 September 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
CYChao Yang
Chao Yang
JSJason R. Siebert
Jason R. Siebert
RBRobert Burns
Robert Burns
ZGZachary J. Gerbec
Zachary J. Gerbec
BBBenedetta Bonacci
Benedetta Bonacci
Subramaniam MalarkannanSubramaniam Malarkannan
Subramaniam Malarkannan
Natural killer (NK) cells are critical to both innate and adaptive immunity. However, the development and heterogeneity of human NK cells are yet to be fully defined. Using single-cell RNA-sequencing technology, here we identify distinct NK populations in human bone marrow and blood, including one population expressing higher levels of immediate early genes indicative of a homeostatic activation. Functionally matured NK cells with high expression of CX3CR1, HAVCR2 (TIM-3), and ZEB2 represents terminally differentiated status with the unique transcriptional profile. Transcriptomic and pseudotime analyses identify a transitional population between CD56bright and CD56dim NK cells. Finally, a donor with GATA2T354M mutation exhibits reduced percentage of CD56bright NK cells with altered transcriptome and elevated cell death. These data expand our understanding of the heterogeneity and development of human NK cells.

1 September 2019 in Cancer Immunology Research
Verified
Journal Article
Closed access
PDF file
WXWenwen Xu
Wenwen Xu
JDJuan Dong
Juan Dong
YZYongwei Zheng
Yongwei Zheng
JZJuan Zhou
Juan Zhou
YYYing Yuan
Ying Yuan
LWLi Lily Wang
Li Lily Wang
Immune-checkpoint protein V-domain immunoglobulin suppressor of T-cell activation (VISTA) controls antitumor immunity and is a valuable target for cancer immunotherapy. This study identified a role of VISTA in regulating Toll-like receptor (TLR) signaling in myeloid cells and controlling myeloid cell–mediated inflammation and immunosuppression. VISTA modulated the polyubiquitination and protein expression of TRAF6. Consequently, VISTA dampened TLR-mediated activation of MAPK/AP-1 and IKK/NF-κB signaling cascades. At cellular levels, VISTA regulated the effector functions of myeloid-derived suppressor cells and tolerogenic dendritic cell (DC) subsets. Blocking VISTA augmented their ability to produce proinflammatory mediators and diminished their T cell–suppressive functions. These myeloid cell–dependent effects resulted in a stimulatory tumor microenvironment that promoted T-cell infiltration and activation. We conclude that VISTA is a critical myeloid cell–intrinsic immune-checkpoint protein and that the reprogramming of tolerogenic myeloid cells following VISTA blockade promotes the development of T cell–mediated antitumor immunity.

27 June 2012 in Mucosal Immunology
Verified
Journal Article
Open access
PDF file
PKP Kumar
P Kumar
MTM S Thakar
M S Thakar
WOW Ouyang
W Ouyang
Subramaniam MalarkannanSubramaniam Malarkannan
Subramaniam Malarkannan
Influenza infection primarily targets the upper respiratory system, leading to a severe destruction of the epithelial cell layer. The role of immune cells in the regeneration of tracheal and bronchial epithelial cells is not well defined. Here, we investigated the production of pro-constructive cytokine, Interleukin-22 (IL-22), in the bronchoalveolar lavage (BAL), trachea, lung tissue, and spleen during influenza infection. We found that conventional natural killer (NK) cells (NCR1+NK1.1+CD127−RORγt−) were the predominant IL-22-producers in the BAL, trachea, and lung tissues. Tracheal epithelial cells constitutively expressed high levels of IL-22R and underwent active proliferation in response to IL-22 in the wild-type mice. Infection of IL-22−/− mice with influenza virus resulted in a severe impairment in the regeneration of tracheal epithelial cells. In addition, IL-22−/− mice continued to lose body weight even after 10 days post infection without any recovery. Tracheal epithelial cell proliferation was significantly reduced in IL-22−/− mice during influenza infection. Adoptive transfer of IL-22-sufficient but not IL-22-deficient NK cells into IL-22−/− mice restored the tracheal/bronchial epithelial cell regeneration and conferred protection against inflammation. Our findings strongly suggest that conventional NK cells have evolved to both kill virus-infected cells and also to provide vital cytokines for tissue regeneration.

12 June 2020 in Cancers
Verified
Journal Article
Open access
PDF file
EHElaheh Hashemi
Elaheh Hashemi
Subramaniam MalarkannanSubramaniam Malarkannan
Subramaniam Malarkannan
Natural killer (NK) cells belong to type 1 innate lymphoid cells (ILC1) and are essential in killing infected or transformed cells. NK cells mediate their effector functions using non-clonotypic germ-line-encoded activation receptors. The utilization of non-polymorphic and conserved activating receptors promoted the conceptual dogma that NK cells are homogeneous with limited but focused immune functions. However, emerging studies reveal that NK cells are highly heterogeneous with divergent immune functions. A distinct combination of several activation and inhibitory receptors form a diverse array of NK cell subsets in both humans and mice. Importantly, one of the central factors that determine NK cell heterogeneity and their divergent functions is their tissue residency. Decades of studies provided strong support that NK cells develop in the bone marrow. However, evolving evidence supports the notion that NK cells also develop and differentiate in tissues. Here, we summarize the molecular basis, phenotypic signatures, and functions of tissue-resident NK cells and compare them with conventional NK cells.

1 June 2015 in Molecular Immunology
Verified
Journal Article
Closed access
AAAlex M. Abel
Alex M. Abel
KSKristina M. Schuldt
Kristina M. Schuldt
KRKamalakannan Rajasekaran
Kamalakannan Rajasekaran
DHDavid Hwang
David Hwang
MRMatthew Riese
Matthew Riese
Subramaniam MalarkannanSubramaniam Malarkannan
Subramaniam Malarkannan